- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 235/10 - Radicals substituted by halogen atoms or nitro radicals
Patent holdings for IPC class C07D 235/10
Total number of patents in this class: 110
10-year publication summary
|
7
|
7
|
9
|
9
|
7
|
8
|
8
|
5
|
6
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline LLC | 539 |
5 |
| Takeda Pharmaceutical Company Limited | 2943 |
4 |
| Kumiai Chemical Industry Co., Ltd. | 317 |
4 |
| Nippon Shinyaku Co., Ltd. | 322 |
4 |
| Merial, Inc. | 225 |
3 |
| Hoffmann-La Roche Inc. | 3267 |
2 |
| Janssen Pharmaceutica N.V. | 3612 |
2 |
| Arizona Board of Regents on behalf of Arizona State University | 2464 |
2 |
| Cornell University | 3202 |
2 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
2 |
| Indiana University Research and Technology Corporation | 800 |
2 |
| Jiangsu Hengrui Medicine Co., Ltd. | 760 |
2 |
| Nanjing Tech University | 239 |
2 |
| Pharmacyclics, Inc. | 107 |
2 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 627 |
2 |
| Vectus Biosystems Limited | 35 |
2 |
| Adamed Pharma S.A. | 134 |
2 |
| Vitae Pharmaceuticals, LLC | 43 |
2 |
| Xiamen Vivohealths Technology Co., Ltd. | 7 |
2 |
| Plex Pharmaceuticals, Inc. | 16 |
2 |
| Other owners | 60 |